Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis

BACKGROUND: A limited number of targeted therapy options exist for papillary thyroid cancer (PTC) to date. Based on genetic alterations reported by the “The Cancer Genome Atlas (TCGA)”, we explored whether PTC shows alterations that may be targetable by drugs approved by the FDA for other solid canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hescheler, Daniel A., Riemann, Burkhard, Hartmann, Milan J. M., Michel, Maximilian, Faust, Michael, Bruns, Christiane J., Alakus, Hakan, Chiapponi, Costanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498581/
https://www.ncbi.nlm.nih.gov/pubmed/34630336
http://dx.doi.org/10.3389/fendo.2021.748941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498581/
https://www.ncbi.nlm.nih.gov/pubmed/34630336
http://dx.doi.org/10.3389/fendo.2021.748941

Ejemplares similares